The 5-Alpha Reductase Inhibitor Finasteride Reduces Dyskinesia in a Rat Model of Parkinson’s Disease

May 2017 in “ Experimental Neurology ”

Roberto Frau, Paola Savoia, Silvia Fanni, Chiara Fiorentini, Camino Fidalgo, Elisabetta Tronci, Roberto Stancampiano, Mario Meloni, Antonino Cannas, Francesco Marrosu, Marco Bortolato, Paola Devoto, Cristina Missale, Manolo Carta

5-alpha reductase inhibitor finasteride D₁ receptor D₂ receptor D3 receptor Propecia

TLDR Finasteride reduces movement issues in Parkinson's disease rats.

The study investigated the effects of the 5-alpha reductase inhibitor finasteride on dyskinesia in a rat model of Parkinson's disease. The results showed that chronic administration of finasteride reduced L-DOPA-induced dyskinesias in the rats. The antidyskinetic effect of finasteride may be exerted via modulation of both the D₁- and D₂/D3 receptor pathways. The study suggests that finasteride may have potential as a treatment for dyskinesia in Parkinson's disease patients.

View this study on sciencedirect.com →

Discuss this study in the Community →

Cited in this study

8 / 8 results

research Neuroactive Gonadal Drugs for Neuroprotection in Male and Female Models of Parkinson's Disease

34 citations , August 2016 in “Neuroscience & Biobehavioral Reviews”

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

research Targeting Neurosteroid Synthesis as a Therapy for Schizophrenia-Related Alterations Induced by Early Psychosocial Stress

24 citations , November 2015 in “Schizophrenia Research”

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

research The 5α-Reductase Inhibitor Dutasteride but Not Finasteride Protects Dopamine Neurons in the MPTP Mouse Model of Parkinson’s Disease

27 citations , October 2015 in “Neuropharmacology”

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The 5-Alpha Reductase Inhibitor Finasteride Reduces Dyskinesia in a Rat Model of Parkinson’s Disease

Cited in this study

research Neuroactive Gonadal Drugs for Neuroprotection in Male and Female Models of Parkinson's Disease

research Targeting Neurosteroid Synthesis as a Therapy for Schizophrenia-Related Alterations Induced by Early Psychosocial Stress

research The 5α-Reductase Inhibitor Dutasteride but Not Finasteride Protects Dopamine Neurons in the MPTP Mouse Model of Parkinson’s Disease

research Finasteride Attenuates Pathological Gambling in Patients With Parkinson's Disease

research A Preliminary Study of Finasteride in Tourette Syndrome

research Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders

research Treatment of Benign Essential Blepharospasm With Finasteride

research Treatment of Tourette’s Syndrome With Finasteride